Entecavir Treatment Prevents Disease Progression in HBV Related Acute-on-Chronic Liver Failure:Establishment of a Novel Logistical Regression Model
Background/Aims:Hepatitis B related acute-on-chronic liver failure has a poor prognosis with very high mortality.Unfortunately,most prognostic predictive models of liver failure are complicated and offer suboptimal sensitivity.Experience in entecavir-treated patients with HBV-ACLF is limited.This study was designed to evaluate the efficacy and safety of entecavir in patients with HBV-ACLF and to develop a novel model (Tongji prognostic predictory model,TPPM) for prognostic prediction of HBV-ACLF patients.
Wei Guo Xiping Zhao Deying Tian Jianxin Song Junying Qi Qin Ning Ke Ma Meifang Han Guang Chen Tao Chen Zen guang Wu Dao fengYang Jiaquan Huang Yuancheng Huang
Department of Infectious Disease,Tongji Hospital of Tongji Medical College,University of Science and Technology,Wuhan,China
国内会议
重庆
英文
101-102
2012-04-12(万方平台首次上网日期,不代表论文的发表时间)